SymBio Pharmaceuticals Market Cap

SymBio Pharmaceuticals has a market cap or net worth of 8.38 billion as of July 16, 2025. Its market cap has increased by 13.58% in one year.

Market Cap

8.38B

Enterprise Value

5.46B

Revenue

2.12B

Ranking

n/a

PE Ratio

n/a

Stock Price

173.00

Market Cap Chart

Since October 20, 2011, SymBio Pharmaceuticals's market cap has increased from 7.08B to 8.38B, an increase of 18.36%. That is a compound annual growth rate of 1.23%.

Market Cap History

Date	Market Cap	% Change
Jul 16, 2025	8.38B	-8.15%
Dec 30, 2024	9.12B	-12.48%
Dec 29, 2023	10.42B	-58.97%
Dec 30, 2022	25.40B	-42.20%
Dec 30, 2021	43.94B	203.74%
Dec 30, 2020	14.47B	-8.66%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Chugai Pharmaceutical	11.27T
Takeda Pharmaceutical Company	7,019.14B
Daiichi Sankyo Company	6,365.29B
HOYA Corporation	6,217.64B
Terumo	3,601.83B
Otsuka Holdings	3,478.27B
Astellas Pharma	2,577.15B
Shionogi &	2,117.78B

Market Cap Rankings